(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of -47.27% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.07%.
Alector's revenue in 2026 is $69,048,000.On average, 11 Wall Street analysts forecast ALEC's revenue for 2026 to be $4,861,824,866, with the lowest ALEC revenue forecast at $450,795,579, and the highest ALEC revenue forecast at $22,039,865,226. On average, 8 Wall Street analysts forecast ALEC's revenue for 2027 to be $2,995,007,240, with the lowest ALEC revenue forecast at $1,283,621,311, and the highest ALEC revenue forecast at $5,008,851,899.
In 2028, ALEC is forecast to generate $1,098,063,808 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $3,146,291,180.